Dr Jackie Fairley's executive career spanned more than 35 years in the Pharma/biotech and animal health industries.
She has worked in senior management roles with ASX-listed companies including CSL, FH Faulding (now Pfizer) and Starpharma, where she served as longstanding CEO and Managing Director. Jackie also has more than 20 years of NED experience across ASX listed and NFP/for-purpose organisations, including 10 years on the board of the Melbourne Business School.
Jackie is currently a non-executive director and member of the Audit & Risk and Investment Committees of ASX-listed Mirrabooka Investments Limited and a non-executive director of the hospitals and aged care group, Calvary Health Care which operates 16 Hospitals and more than 70 aged care facilities in Australia. She is also an Industrial Advisor to the global PE firm EQT and a member of the Victorian Trade and Investment Advisory Board. Jackie has previously served on multiple Ministerial advisory groups including the Federal Government’s Commonwealth Science Council and other groups spanning pharmaceuticals, economic development and innovation.